Improved effectiveness of biochanin A as a P-gp inhibitor in solid dispersion

Pharmazie

Volumn 66, Issue 9, 2011, Pages 710-715

  Han, Hyo Kyung ^a   Lee, Hyoung Kyu ^b  

^a Dongguk University   (South Korea)

^b Chosun University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHANIN A; DEACETYLDILTIAZEM; DILTIAZEM; DRUG METABOLITE; GLYCOPROTEIN P INHIBITOR; HYDROXYPROPYLMETHYLCELLULOSE; RHODAMINE 123; SOLUTOL HS 15;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CELL TRANSPORT; CONTROLLED STUDY; DRUG ABSORPTION; DRUG EFFICACY; DRUG FORMULATION; HUMAN; HUMAN CELL; IN VIVO STUDY; INTESTINE ABSORPTION; MALE; NONHUMAN; RAT; SOLID DISPERSION;

ADMINISTRATION, ORAL; ANIMALS; ANTICARCINOGENIC AGENTS; BIOTRANSFORMATION; CALCIUM CHANNEL BLOCKERS; CELL LINE; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DILTIAZEM; DRUG CARRIERS; GENISTEIN; HUMANS; INJECTIONS, INTRAVENOUS; MALE; METHYLCELLULOSE; P-GLYCOPROTEIN; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY;

EID: 84055217418     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2011.1028     Document Type: Article

References (36)

1. Ahuja N, Katare OP, Singh B (2007) Studies on dissolution enhancement and mathematical modeling of drug release of a poorlywater-soluble drug using water-soluble carriers. Eur J Pharm Biopharm 65: 26-38. (Pubitemid 44827692)
2. Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM (1999) Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 39: 361-398. (Pubitemid 29222564)
3. Asberg A, Christensen H, Hartmann A, Carlson E, Molden E, Berg KJ (1999) Pharmacokinetic interactions between microemulsion formulated cyclosporine A and diltiazem in renal transplant recipients. Eur J Clin Pharmacol 55: 383-387. (Pubitemid 29344082)
4. Atkinson C, Compston J E, Day NE, Dowsett M, Bingham SA (2004) The effects of phytoestrogen isoflavones on bone density in women: a doubleblind, randomized, placebo-controlled trial. Am J Clin Nutr 79: 326-333. (Pubitemid 41095988)
5. Bittner B, González RC, Walter I, Kapps M, Huwyler J (2003) Impact of Solutol HS 15 on the pharmacokinetic behaviour of colchicine upon intravenous administration to male Wistar rats. Biopharm Drug Dispos 24: 173-181. (Pubitemid 36656391)
6. Booth NL, Piersen CE, Banuvar S, Geller SE, Shulman LP, Farnsworth NR (2006) Clinical studies of red clover (Trifolium pratense) dietary supplements in menopause: a literature review. Menopause 13: 251-264.
7. Castro AF, Altenberg GA (1997) Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein. Biochem Pharmacol 53: 89-93. (Pubitemid 26419790)
8. Choi JS, Choi HK, Shin SC (2004) Enhanced bioavailability of paclitaxel after the oral coadministration with flavone in rats. Int J Pharm 275: 165-170.
9. Coon JS, Knudson W, Clodfelter K, Lu B,Weinstein RS (1991) Solutol HS 15, nontoxic polyoxyethylene esters of 12-hydroxystearic acid, reverses multidrug resistance. Cancer Res 51: 897-902.
10. Coon JT, Pittler MH, Ernst E (2007) Trifolium pratense isoflavones in the treatment of menopausal hot flushes: a systematic review and metaanalysis. Phytomedicine 14: 153-159. (Pubitemid 46136954)
11. Germann UA (1996) P-Glycoprotein-a mediator of multidrug resistance in tumour cells. Eur J Cancer 32A: 927-944.
12. Goebel KJ, Kolle EU (1985) High-performance liquid chromatographic determination of diltiazem and four of its metabolites in plasma. Application to pharmacokinetics. J Chromatogr 345: 355-363.
13. Han HK, Lee BJ, Lee HK (2011) Enhanced dissolution and bioavailability of biochanin A, poorly soluble bioflavonoid, via the preparation of solid dispersion: in vitro and in vivo evaluation., Int J Pharm, in press.
14. Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455: 152-162.
15. Kartner N, Riordan JR, Ling V (1983) Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science 221: 1285-1288. (Pubitemid 13005502)
16. Kiyomoto A, Sasaki Y, Odawara A, Morita T (1983) Inhibition of platelet aggregation by diltiazem. Comparison with verapamil and nifedipine and inhibitory potencies of diltiazem metabolites. Circ Res 52: I115-119.
17. Krenn L, Unterrieder I, Ruprechter R (2002) Quantification of isoflavones in red clover by high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 777: 123-128. (Pubitemid 35257866)
18. Laurenzana EM, Weis CC, Bryant CW, Newbold R, Delclos KB (2002) Effect of dietary administration of genistein, nonylphenol or ethinyl estradiol on hepatic testosterone metabolism, cytochrome P-450 enzymes, and estrogen receptor alpha expression. Food Chem Toxicol 40: 53-63. (Pubitemid 33132141)
19. Li R, Farmer PS, Xie M, Quilliam MA, Pleasance S, Howlett SE, Yeung PK (1992) Synthesis, characterization, and Ca2+ antagonistic activity of diltiazem metabolites. J Med Chem 35: 3246-3253.
20. Middleton E, Jr. Kandaswami C, Theoharides TC (2000) The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52: 673-751.
21. Molden E, Asberg A, Christensen H (2000) CYP2D6 is involved in Odemethylation of diltiazem. An in vitro study with transfected human liver cells. Eur J Clin Pharmacol 56: 575-579.
22. Moon YJ, Sagawa K, Frederick K, Zhang S, Morris ME (2006) Pharmacokinetics and bioavailability of the isoflavone biochanin A in rats. AAPS J 8: E433-442. (Pubitemid 44096604)
23. Peng SX, Ritchie DM, Cousineau M, Danser E, Dewire R, Floden J (2006) Altered the oral bioavailability and pharmacokinetics of Pglycoprotein substrates by coadministration of biochanin A. J Pharm Sci 95: 1984-1993. (Pubitemid 44433029)
24. Pichard L, Gillet G, Fabre I, Dalet-Beluche I, Bonfils C, Thenot JP, Maurel P (1990) Identification of the rabbit human cytochromes P-450IIIA as the major enzymes involved in the N-demethylation of diltiazem. Drug Metab Dispos 18: 711-719. (Pubitemid 20348865)
25. Qiang F, Lee BJ, Ha I, Kang KW, Woo ER, Han HK (2010) Effect of maceligan on the systemic exposure of paclitaxel: in vitro and in vivo evaluation. Eur J Pharm Sci 41: 226-231.
26. Risbridger GP,Wang H, FrydenbergM, HusbandA(2001) The in vivo effect of red clover diet on ventral prostate growth in adult male mice. Reprod Fertil Dev 13: 325-329. (Pubitemid 33133351)
27. Vasconcelos T, Sarmento B, Costa P (2007) Solid dispersions as strategy to improve the oral bioavailability of poor water soluble drugs. Drug Discov Today 12: 1068-1075. (Pubitemid 350186132)
28. Wacher VJ, Salphati L, Benet LZ (2001) Active secretion and enterocytic drug metabolism barriers to drug absorption. Adv Drug Deliv Rev 46: 89-102.
29. Wacher VJ, Wu CY, Benet LZ (1995) Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol Carcinog 13: 129-134.
30. Xu D, Lu Q, Hu X (2006) Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol. Cancer Lett 243: 274-280. (Pubitemid 44485849)
31. Yabana H, Nagao T, Sato M (1985) Cardiovascular effects of the metabolites of diltiazem in dogs. J Cardiovasc Pharmacol 7: 152-157. (Pubitemid 15162258)
32. Yusa K, Tsuruo T (1989) Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells. Cancer Res 49: 5002-5006. (Pubitemid 19239333)
33. Zhang S, Morris ME (2003a) Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport. J Pharmacol Exp Ther 304: 1258-1267. (Pubitemid 36254439)
34. Zhang S, Morris ME (2003b) Effect of the flavonoids biochanin A and silymarin on the P-glycoprotein-mediated transport of digoxin and vinblastine in human intestinal Caco-2 cells. Pharm Res 20: 1184-1191. (Pubitemid 36951843)
35. Zhang S, Sagawa K, Arnold RD, Tseng E,Wang X, Morris ME (2010) Interactions between the flavonoid biochanin A and P-glycoprotein substrates in rats: in vitro and in vivo. J Pharm Sci 99: 430-441.
36. Zhang S, Yang X, Morris ME (2004) Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport. Mol Pharmacol 65: 1208-1216. (Pubitemid 38543491)